The Next Phase: Exploring Innovation in Clinical Trials Data Powering Actionable Outcomes in Clinical Trials
Jul 29, 2021
Tracey Robertson, Global Process Lead at Boehringer Ingelheim, discusses the transformational impact of real-world data in clinical trials. She highlights how digital technologies can enhance patient and site experiences while ensuring effective and scalable trial methodologies. The conversation delves into the importance of patient centricity, navigating regulatory landscapes, and the need for strategic planning in tech adoption. Tracey emphasizes empowering participants with their health data to foster greater engagement and understanding in clinical research.
AI Snips
Chapters
Transcript
Episode notes
Expanding Role of Real-World Data
- Real-world data enriches clinical trials by providing detailed context before, during, and after trials.
- It helps demonstrate drug value post-trial, supporting regulatory and pricing decisions.
Balancing Big Data and Trial Control
- Clinical trials traditionally focus on controlled environments, but big data introduces volume, variety, and velocity challenging that control.
- Balancing between collecting extensive data and focusing on specific scientific questions is critical to avoid slowing drug development.
Choose Scalable Technology Early
- Prioritize technology solutions that can scale organization's global operations, not just pilots.
- Consider regulatory and organizational barriers early to ensure sustainable technology adoption.